Adaptive neurology in COVID-19 times

por Moro, Elena, Fernandez, Hubert H.
Publicado 2020

Role of rasagiline in treating Parkinson’s disease: Effect on disease progression

por Malaty, Irene A, Fernandez, Hubert H
Publicado 2009

MRI-based multivariate gray matter volumetric distance for predicting motor symptom progression in Parkinson's disease

por Vijayakumari, Anupa A., Fernandez, Hubert H., Walter, Benjamin L.
Publicado 2023

Author Correction: MRI-based multivariate gray matter volumetric distance for predicting motor symptom progression in Parkinson's disease

por Vijayakumari, Anupa A., Fernandez, Hubert H., Walter, Benjamin L.
Publicado 2023

Reply to letter: Suicide in Parkinson's disease patients treated with levodopa‐carbidopa Intestinal Gel

por Fernandez, Hubert H., Standaert, David G., Chatamra, Krai, Benesh, Janet A.
Publicado 2015

Deep Brain Stimulation in Parkinson's Disease

por Mehanna, Raja, Fernandez, Hubert H., Wagle Shukla, Aparna, Bajwa, Jawad A.
Publicado 2018

Mild cognitive impairment in Parkinson’s disease: the challenge and the promise

por Fernandez, Hubert H, Crucian, Gregory P, Okun, Michael S, Price, Catherine C, Bowers, Dawn
Publicado 2005

Height and weight changes after deep brain stimulation in patients with Parkinson disease: role of clinical subtypes

por Abboud, Hesham, Reyes, Dennys, Genc, Gencer, Ahmed, Anwar, Gostkowski, Michal, Fernandez, Hubert H.
Publicado 2019

ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum

por Salles, Philippe A., Mata, Ignacio F., Brünger, Tobias, Lal, Dennis, Fernandez, Hubert H.
Publicado 2021

Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review

por Garcia, Xiomara, Mohammad, Mohammad Edrees, Patel, Shnehal, Yu, Xin Xin, Fernandez, Hubert H.
Publicado 2022

A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies

por Salles, Philippe A., Liao, James, Shuaib, Umar, Mata, Ignacio F., Fernandez, Hubert H.
Publicado 2022

Clinical and programming pattern of patients with impending deep brain stimulation power failure: a retrospective chart review

por Mehanna, Raja, Wilson, Kathy M, Cooper, Scott E, Machado, Andre G, Fernandez, Hubert H
Publicado 2014

Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort

por Okun, Michael S, Wu, Samuel S, Jennings, Dana, Marek, Kenneth, Rodriguez, Ramon L, Fernandez, Hubert H
Publicado 2014

Cognitive decline tracks motor progression and not disease duration in Parkinson patients

por Riggeal, BD, Crucian, GP, Seignourel, P, Jacobson, CE, Okun, MS, Rodriguez, RL, Fernandez, Hubert H
Publicado 2007

Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use

por Cooper, Christine A, Jadidian, Armon, Paggi, Michelle, Romrell, Janet, Okun, Michael S, Rodriguez, Ramon L, Fernandez, Hubert H
Publicado 2009

Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease

por Fernandez, Hubert H, Robieson, Weining Z, Chatamra, Krai, Dubow, Jordan, Eaton, Susan, Benesh, Janet A, Odin, Per
Publicado 2016

Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia

por Fernandez, Hubert H., Pagan, Fernando, Danisi, Fabio, Greeley, David, Jankovic, Joseph, Verma, Amit, Sethi, Kapil, Pappert, Eric J.
Publicado 2013

Implementing Levodopa‐Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners

por Burack, Michelle, Aldred, Jason, Zadikoff, Cindy, Vanagunas, Arvydas, Klos, Kevin, Bilir, Bahri, Fernandez, Hubert H., Standaert, David G.
Publicado 2018

Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

por Mohammad, Mohammad Edrees, Vizcarra, Joaquin A., Garcia, Xiomara, Patel, Shnehal, Margolius, Adam, Yu, Xin Xin, Fernandez, Hubert H.
Publicado 2021

Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm

por Truong, Daniel D., Gollomp, Stephen M., Jankovic, Joseph, LeWitt, Peter A., Marx, Michael, Hanschmann, Angelika, Fernandez, Hubert H.
Publicado 2013